v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss (including amounts attributable to redeemable non-controlling interests) $ (130,786) $ (104,047) $ (130,429)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Stock-based compensation 143,738 115,140 97,232
Amortization of deferred contract costs 41,267 35,014 29,788
Depreciation and amortization 19,328 10,115 6,963
Provision for credit losses 666 2,331 2,020
Value of common stock donated to charity 3,223 3,776 3,762
Accretion of discount on marketable securities (951) (2,079) (2,077)
Non-cash foreign exchange (gain) loss (73) (1,033) 460
Fair value adjustments to contingent consideration 0 (223) (1,572)
Fixed asset write offs 80 488 146
Other (144) (152) (495)
Changes in operating assets and liabilities:      
Accounts receivable (22,715) (5,363) (14,008)
Prepaid expenses and other current assets 3,569 (6,629) (3,413)
Deferred contract costs (65,249) (48,171) (45,119)
ROU assets and liabilities (1,133) 1,939 4,275
Other assets (1,880) (29) 229
Accounts payable (601) (3,912) 3,419
Accrued expenses and other current liabilities 26,191 3,694 20,990
Deferred revenue 57,137 35,887 34,108
Other long-term liabilities (229) (66) 571
Net cash provided by operating activities 71,438 36,680 6,850
CASH FLOWS FROM INVESTING ACTIVITIES:      
Cash paid for acquisition, net of cash acquired (181,854) 0 (16,319)
Purchases of property and equipment (9,588) (13,234) (9,761)
Capitalized internal-use software costs (3,776) (3,814) (3,574)
Purchases of marketable securities (151,641) (217,975) (248,059)
Maturities of marketable securities 175,208 195,353 257,737
Return of principal on marketable securities 120,744 3,200 0
Net cash used in investing activities (50,907) (36,470) (19,976)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from exercise of common stock options 15,861 6,906 7,263
Proceeds from stock associated with employee stock purchase plan 7,099 7,705 6,011
Payments of deferred purchase consideration 0 (2,916) (165)
Net cash provided by financing activities 22,960 11,695 13,109
Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash 1,255 (444) (475)
Net change in cash, cash equivalents, and restricted cash 44,746 11,461 (492)
Cash, cash equivalents, and restricted cash, beginning of period 83,592 72,131 72,623
Cash, cash equivalents, and restricted cash, end of period 128,338 83,592 72,131
SUPPLEMENTAL CASH FLOW DISCLOSURE:      
Cash paid for income taxes, net of refunds 3,896 2,945 309
NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Stock-based compensation capitalized to internal-use software 2,073 2,259 2,152
Unrealized net gain on marketable investment securities 483 1,058 5,416
Net change to property and equipment (included in accounts payable / accrued liabilities) (259) 173 208
Asset retirement obligation 38 34 62
Common stock issuance, acquisition (107,629) 0 (6,121)
Contingent consideration, acquisition 0 0 (1,795)
Indemnity escrows, acquisition $ (3,128) $ 0 $ (3,081)